Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in Recurrent Uterine Leiomyosarcoma
NCT00003316Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Aug 1998
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gemcitabine in uterine leiomyosarcoma (uLMS), sponsored by GOG Foundation. Started Aug 1998; status: terminated.
02
Drugs
gemcitabine
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT00003316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003316.